DF Dent & Co’s Charles River Laboratories CRL Stock Holding History

DF Dent & Co’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-74,672	Closed	-$11.7M	–	269
2025 Q3	$11.7M	Sell	74,672 -87,788	-54%	-$13.9M	0.15%	95
2025 Q2	$24.7M	Buy	162,460 +47,472	+41%	+$6.33M	0.31%	75
2025 Q1	$17.3M	Buy	114,988 +2,458	+2%	+$412K	0.23%	82
2024 Q4	$20.8M	Sell	112,530 -7,515	-6%	-$1.45M	0.26%	81
2024 Q3	$23.6M	Buy	120,045 +23,774	+25%	+$4.94M	0.29%	74
2024 Q2	$19.9M	Buy	96,271 +28,918	+43%	+$6.55M	0.26%	71
2024 Q1	$18.2M	Sell	67,353 -428	-0.6%	-$102K	0.22%	67
2023 Q4	$16M	Buy	67,781 +19,023	+39%	+$3.74M	0.21%	68
2023 Q3	$9.56M	Sell	48,758 -300	-0.6%	-$61.6K	0.14%	83
2023 Q2	$10.3M	Buy	+49,058	New	+$9.76M	0.14%	83

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

DF Dent & Co's CRL Position: Q4 2025 in Review

DF Dent & Co sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 74,672 shares — an estimated $11.7M sold.

DF Dent & Co first reported a position in CRL in Q2 2023 and held it in 10 quarters. The position peaked at $24.7M in Q2 2025. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

DF Dent & Co reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
DF Dent & Co sold 74,672 Charles River Laboratories shares in Q4 2025, an estimated $11.7M.
DF Dent & Co first reported a position in Charles River Laboratories in Q2 2023 and held it in 10 quarters.
DF Dent & Co's Charles River Laboratories position peaked at $24.7M in Q2 2025.
582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on DF Dent & Co's 13F filing for Q4 2025, filed 17 Feb 2026.